To establish the validity of our mice models with metabolic syndrome and the efficacy of the six month HFD treatment, we assessed four vital parameters that are indicative of metabolic disorders: obesity, glucose intolerance, insulin insensitivity, and high blood cholesterol. This evidence concerns the gene INS and glucose measurement.